Mckesson Corp
NYSE:MCK
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
584.38
888.4524
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
MCK
stock under the Base Case scenario is
1 266.15
USD.
Compared to the current market price of 836.92 USD,
Mckesson Corp
is
Undervalued by 34%.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Mckesson Corp.
Fundamental Analysis
MCK Profitability Score
Profitability Due Diligence
Score
MCK Solvency Score
Solvency Due Diligence
Score
Select up to 3 indicators:
Select up to 3 indicators:
McKesson’s heavy reliance on large pharmaceutical manufacturers and payers could result in margin pressures if partners consolidate or aggressively negotiate prices, hurting profitability.
Potential disruptions to McKesson’s supply chain, particularly in generic drug procurement, risk creating unexpected shortages or higher costs that cannot be easily passed on to customers.
Regulatory scrutiny over pharmaceutical distribution practices, including opioid handling, may lead to costly legal settlements or additional compliance requirements, eroding earnings.
The company’s massive distribution scale and long-standing relationships with healthcare providers position McKesson to weather competitive pressures and maintain stable margins.
McKesson’s strategic focus on technology solutions, such as advanced analytics and supply chain software, could unlock incremental revenue streams and reinforce customer loyalty.
Expanding specialty drug distribution, including oncology and specialty therapies, provides a higher-margin growth avenue that could meaningfully boost McKesson’s profitability over time.
Revenue & Expenses Breakdown
Mckesson Corp
Balance Sheet Decomposition
Mckesson Corp
Mckesson Corp
Free Cash Flow Analysis
Mckesson Corp
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
Mckesson Corp
Wall St
Price Targets
MCK Price Targets Summary
Mckesson Corp
According to Wall Street analysts, the average 1-year price target for
MCK
is 955.45 USD
with a low forecast of 765.08 USD and a high forecast of 1 050 USD.
Dividends
Current shareholder yield for
MCK is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
MCK
stock under the Base Case scenario is
1 266.15
USD.
Compared to the current market price of 836.92 USD,
Mckesson Corp
is
Undervalued by 34%.